Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04869813 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)

Study acronym: SUSIE
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Jul 31, 2026 → Jan 31, 2027
See other at-risk trials from The Cleveland Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 31, 2026 to Jan 31, 2027
    • Study completion pushed from Dec 31, 2026 to Dec 31, 2027
    • Eligibility criteria expanded, about 20 words
  2. Trial status changed: Recruiting → Enrolling by Invitation
    • Primary completion pushed from Jun 30, 2026 to Jul 31, 2026
    • Site details revised
    v8
  3. Primary completion date: Dec 31, 2025 to Jun 30, 2026
    • Study completion date: Apr 30, 2026 to Dec 31, 2026
    v7
  4. Primary completion date: Apr 30, 2025 to Dec 31, 2025v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Apr 30, 2024 to Apr 30, 2025
    • Study completion date: Apr 30, 2025 to Apr 30, 2026
    v4
  2. 2 versions Re-verified since Mar 9, 2022, no change to tracked fieldsv2-v3
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of the proposed research is to investigate Magnetic Resonance (MR) Fingerprinting and P-MRS (Phosphorus-31 MR Spectroscopy) imaging for characterization of skeletal muscle in heart failure patients with sarcopenia. Heart failure patients with and without sarcopenia will be scanned using MR Fingerprinting and an existing Post-exercise phosphocreatine (PCr) recovery MR imaging protocol to obtain characteristic profiles of quantitative T1, T2, and PCr recovery rate.
Trial Details
NCT Number NCT04869813
Lead Sponsor The Cleveland Clinic
Conditions
(from sponsor)		 Sarcopenia
Related terms Sarcopenia
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov